Evidence map›Paper›PMID 39444513›Full record

ArticleProceedings of SPIE--the International Society for Optical Engineering2024

Treatment-wise Glioblastoma Survival Inference with Multi-parametric Preoperative MRI.

Xiaofeng Liu, Nadya Shusharina, Helen A Shih, C-C Jay Kuo, Georges El Fakhri, Jonghye Woo

Abstract read
In one paragraph

Article in Proceedings of SPIE--the International Society for Optical Engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Individualized Treatment Effect Inference of Head and Neck Cancer with Multimodal Data.APSIPA Transactions on Signal and Information Processing · 2026
    Article
  2. Article
  3. DUAL PROMPTING FOR DIVERSE COUNT-LEVEL PET DENOISING.Proceedings. IEEE International Symposium on Biomedical Imaging · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaofeng LiuGordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA.
Nadya ShusharinaDept. of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Helen A ShihDept. of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
C-C Jay KuoDept. of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA 90007, USA.
Georges El FakhriDept. of Radiology and Biomedical Imaging, Yale University, New Heaven, CT 06519, USA.
Jonghye WooGordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA.

Funding

Unified Joint Statistical Reconstruction of PET & MRP41EB022544 · NIBIB · YALE UNIVERSITY · PI Georges El Fakhri · 2017 to 2026
$14.8M
Quantitative Oncologic PET-MRR01CA165221 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2012 to 2023
$4.7M
NCI NIH HHS R01 CA165221NIBIB NIH HHS P41 EB022544
6 · The paper itself

Abstract

In this work, we aim to predict the survival time (ST) of glioblastoma (GBM) patients undergoing different treatments based on preoperative magnetic resonance (MR) scans. The personalized and precise treatment planning can be achieved by comparing the ST of different treatments. It is well established that both the current status of the patient (as represented by the MR scans) and the choice of treatment are the cause of ST. While previous related MR-based glioblastoma ST studies have focused only on the direct mapping of MR scans to ST, they have not included the underlying causal relationship between treatments and ST. To address this limitation, we propose a treatment-conditioned regression model for glioblastoma ST that incorporates treatment information in addition to MR scans. Our approach allows us to effectively utilize the data from all of the treatments in a unified manner, rather than having to train separate models for each of the treatments. Furthermore, treatment can be effectively injected into each convolutional layer through the adaptive instance normalization we employ. We evaluate our framework on the BraTS20 ST prediction task. Three treatment options are considered: Gross Total Resection (GTR), Subtotal Resection (STR), and no resection. The evaluation results demonstrate the effectiveness of injecting the treatment for estimating GBM survival.

Indexed as

GlioblastomaIndividualized Treatment EffectMagnetic Resonance ImagingSurvival Prediction

Identifiers

PMID39444513
PMCPMC11497473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.